Correlation Between National CineMedia and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both National CineMedia and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National CineMedia and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National CineMedia and Biodexa Pharmaceticals, you can compare the effects of market volatilities on National CineMedia and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National CineMedia with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of National CineMedia and Biodexa Pharmaceticals.
Diversification Opportunities for National CineMedia and Biodexa Pharmaceticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between National and Biodexa is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding National CineMedia and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and National CineMedia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National CineMedia are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of National CineMedia i.e., National CineMedia and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between National CineMedia and Biodexa Pharmaceticals
Given the investment horizon of 90 days National CineMedia is expected to generate 5.56 times less return on investment than Biodexa Pharmaceticals. But when comparing it to its historical volatility, National CineMedia is 1.83 times less risky than Biodexa Pharmaceticals. It trades about 0.03 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 400.00 in Biodexa Pharmaceticals on October 20, 2024 and sell it today you would earn a total of 28.00 from holding Biodexa Pharmaceticals or generate 7.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
National CineMedia vs. Biodexa Pharmaceticals
Performance |
Timeline |
National CineMedia |
Biodexa Pharmaceticals |
National CineMedia and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with National CineMedia and Biodexa Pharmaceticals
The main advantage of trading using opposite National CineMedia and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National CineMedia position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.National CineMedia vs. MGO Global Common | National CineMedia vs. Baosheng Media Group | National CineMedia vs. Glory Star New | National CineMedia vs. Impact Fusion International |
Biodexa Pharmaceticals vs. Motorsport Gaming Us | Biodexa Pharmaceticals vs. SohuCom | Biodexa Pharmaceticals vs. NetEase | Biodexa Pharmaceticals vs. Bowhead Specialty Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data |